Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
.png)
AI computing power expansion boosts interconnection demand Evercore bullish on the prospects of multiple semiconductor manufacturers

A bid of $32 per share soon? Paramount Skydance (PSKY.US) increases efforts to acquire Warner Bros. Discovery (WBD.US).

ADD NEW ENERGY (02623) plans to invest approximately 39.5 million Australian dollars to subscribe for approximately 9.95% equity of Australian gold producer Horizon Minerals Limited. Resumption of trading will take place on February 24th.
AI computing power expansion boosts interconnection demand Evercore bullish on the prospects of multiple semiconductor manufacturers
.png)
A bid of $32 per share soon? Paramount Skydance (PSKY.US) increases efforts to acquire Warner Bros. Discovery (WBD.US).

ADD NEW ENERGY (02623) plans to invest approximately 39.5 million Australian dollars to subscribe for approximately 9.95% equity of Australian gold producer Horizon Minerals Limited. Resumption of trading will take place on February 24th.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


